Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.
Click the orange button to the right to learn more about what you can start doing today.
The list of health benefits of omega-3 fatty acids (fish oil) listed below may seem endless. And it might seem impossible for daily dose of omega-3 fatty acids to provide all the of the health and multipleContinue reading
“Given all this information, people who are on Xarelto, or those caring for those who are, may have some concerns. Experts say it’s best to take those concerns straight to the doctor or specialistContinue reading
“More than one-third of patients with DVT will develop PTS, and 5% to 10% of patients will develop severe PTS, which may manifest as venous ulceration…” I was diagnosed with multipleContinue reading
“It is well known that early treatment is crucial for the prognosis of many types of cancer, and our findings show that an arterial thrombosis in the leg is associated with an increased risk…” IContinue reading
The effects of this damage (myocardial toxicity) can be severe, condemning the cancer survivor to chronic heart disease and even causing premature death…. I was diagnosed with chemotherapy-inducedContinue reading
Multiple Myeloma-Anticipation of the period of greatest risk and recognition of patients with subclinical myocardial dysfunction may prevent clinical heart failure (HF)- I underwent an autologous stemContinue reading
“patients with advanced cancer admitted to specialist palliative care units (SPCUs) found that 1 in 3 had deep vein thrombosis and that thromboprophylaxis may have little benefit for late-stage disease.” PatientsContinue reading
Therapies for multiple myeloma are extremely effective, with overall response rates approaching 100% with initial therapy.3 In general, treatments are well tolerated but do carry some specific CardiovascularContinue reading
“An analysis of past studies shows 18 percent of multiple myeloma patients receiving carfilzomib experience cardiovascular adverse events (CVAE) such as hypertension, heart failure, heart attacks,Continue reading